We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$6.49B
AUM Growth
-$91.2M
Cap. Flow
-$150M
Cap. Flow %
-2.31%
Top 10 Hldgs %
18.45%
Holding
1,603
New
478
Increased
239
Reduced
260
Closed
489

Sector Composition

Rank Sector Weight
1 Communication Services 3.18%
2 Healthcare 3.02%
3 Financials 2.03%
4 Technology 1.9%
5 Consumer Discretionary 0.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAR icon
576
PUT
PAR Technology
PAR
$699M
$1.36M 0.02%
28,800
APTV icon
577
Aptiv
APTV
$12B
$1.35M 0.02%
19,200
+10,900
+131% +$838K
DXCM icon
578
DexCom
DXCM
$31.5B
$1.35M 0.02%
+11,900
New +$1.5M
UTZ icon
579
CALL
Utz Brands
UTZ
$1.25B
$1.35M 0.02%
81,000
UTZ icon
580
PUT
Utz Brands
UTZ
$1.25B
$1.35M 0.02%
81,000
OKE icon
581
CALL
Oneok
OKE
$57.2B
$1.35M 0.02%
16,500
-319,200
-95% -$25.5M
DLTR icon
582
Dollar Tree
DLTR
$24.4B
$1.33M 0.02%
+12,500
New +$1.48M
CVX icon
583
Chevron
CVX
$392B
$1.33M 0.02%
+8,475
New +$1.35M
FOUR icon
584
PUT
Shift4
FOUR
$4.2B
$1.32M 0.02%
+18,000
New +$1.19M
KEX icon
585
CALL
Kirby Corp
KEX
$7.01B
$1.32M 0.02%
11,000
MU icon
586
CALL
Micron Technology
MU
$930B
$1.32M 0.02%
+10,000
New +$1.26M
ROIV icon
587
Roivant Sciences
ROIV
$24.5B
$1.31M 0.02%
+124,330
New +$1.36M
FCX icon
588
CALL
Freeport-McMoran
FCX
$90B
$1.31M 0.02%
27,000
-130,500
-83% -$6.58M
RXRX icon
589
CALL
Recursion Pharmaceuticals
RXRX
$1.59B
$1.31M 0.02%
174,700
+64,700
+59% +$564K
CYRX icon
590
CALL
CryoPort
CYRX
$761M
$1.31M 0.02%
189,500
-110,500
-37% -$1.49M
FLEX icon
591
Flex
FLEX
$41.7B
$1.31M 0.02%
44,400
-88,100
-66% -$2.64M
FYBR
592
PUT
DELISTED
Frontier Communications
FYBR
$1.31M 0.02%
50,000
CRSP icon
593
CRISPR Therapeutics
CRSP
$4.73B
$1.3M 0.02%
+24,139
New +$1.4M
FULC icon
594
PUT
Fulcrum Therapeutics
FULC
$273M
$1.3M 0.02%
210,000
+105,500
+101% +$799K
ZTS icon
595
Zoetis
ZTS
$32.4B
$1.3M 0.02%
+7,500
New +$1.25M
VRDN icon
596
PUT
Viridian Therapeutics
VRDN
$2.09B
$1.3M 0.02%
99,700
-300
-0.3% -$4.15K
SU icon
597
Suncor Energy
SU
$79.4B
$1.3M 0.02%
+34,000
New +$1.31M
PBF icon
598
PBF Energy
PBF
$8.57B
$1.29M 0.02%
+28,119
New +$1.44M
EW icon
599
Edwards Lifesciences
EW
$49.6B
$1.29M 0.02%
+14,000
New +$1.24M
RCKT icon
600
CALL
Rocket Pharmaceuticals
RCKT
$340M
$1.29M 0.02%
60,000
+30,000
+100% +$689K

Similar funds

Caption Management's Q2 2024 Portfolio in Review

As of Q2 2024, Caption Management held 1,603 positions worth $6.49B, down 1.4% from $6.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management's Q2 2024 filing shows 478 new, 239 increased, 260 reduced and 489 closed positions. Its largest new stake was Alphabet (Google) Class C: 233,700 shares worth $42.9M. The largest sale was Meta Platforms (Facebook), an estimated $25.5M.

By sector, the portfolio is most concentrated in Communication Services at 3.2% of assets, up from 2.6% a quarter earlier, followed by Healthcare and Financials.

  • Caption Management's largest Q2 2024 buy was Alphabet (Google) Class C: 233,700 shares worth $42.9M.
  • Caption Management added most to First Solar in Q2 2024, an estimated $18.5M increase.
  • Caption Management's biggest Q2 2024 reduction was Intra-Cellular Therapies Inc., cutting an estimated $18.5M.
  • Caption Management fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $25.5M.
  • Caption Management's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2024.
  • Caption Management opened 478 new positions and closed 489 in Q2 2024.
  • Caption Management's portfolio value fell 1.4% quarter-over-quarter to $6.49B.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.